Desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus, and for the management of primary nocturnal enuresis. Aurobindo has ...
Nocturia is fairly prevalent. A review by Bosch and Weiss [3] noted that most older men and women experience at least 1 void per night and on average two thirds of patients experience 2 or more voids ...
Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE® Nasal Spray 1.5 mg/mL listed ...
Diabetes insipidus occurs when problems with antidiuretic hormone (ADH) cause the body to remove too much water. A synthetic version of ADH can help restore a person’s levels and treat some types of ...
The FDA has assigned a Prescription Drug User Fee Act target date of February 25, 2026 to the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ET-600 ...
DEER PARK, Ill., July 08, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results